Grown Rogue International (GRUSF) Curent Deferred Tax Liability (2021 - 2023)
Grown Rogue International's (GRUSF) quarterly Curent Deferred Tax Liability came in at $366056.0 in Q2 2023, up 17.69% quarter-over-quarter from $311032.0 in Q1 2023.
Grown Rogue International (GRUSF) Curent Deferred Tax Liability (2021 - 2023) Analysis & Trends
Grown Rogue International's Curent Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $366056.0 for Q2 2023.
- On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $366056.0 in Q2 2023; TTM through Apr 2023 was $366056.0, a N/A change from a year earlier, with the FY2022 full-year figure at $311032.0, up 22.15% from the prior year.
- Curent Deferred Tax Liability grew to $366056.0 in Q2 2023 per GRUSF's latest filing, from $311032.0 in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $366056.0 in Q2 2023 and bottomed at $254631.0 in Q4 2021.
- The 3-year median for Curent Deferred Tax Liability is $311032.0 (2022), against an average of $310687.8.
- Biggest YoY gain for Curent Deferred Tax Liability was 22.15% in 2022; the steepest drop was 22.15% in 2022.
- Year by year, Curent Deferred Tax Liability stood at $254631.0 in 2021, then climbed by 22.15% to $311032.0 in 2022, then advanced by 17.69% to $366056.0 in 2023.
- Per Business Quant, the three latest GRUSF Curent Deferred Tax Liability figures stand at $366056.0 (Q2 2023), $311032.0 (Q1 2023), and $311032.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2023 | 366,056.00 |
| Apr 30, 2023 | 366,056.00 |
| Jan 31, 2023 | 311,032.00 |
| Jan 31, 2023 | 311,032.00 |
| Oct 31, 2022 | 311,032.00 |
| Oct 31, 2022 | 311,032.00 |
| Oct 31, 2021 | 254,631.00 |
| Oct 31, 2021 | 254,631.00 |